CD20 antibody [L26] reacts with a protein of a 30-33 kDa polypeptide present in B-cells. L26 has been shown to react with the majority of B-cells present in peripheral blood and lymphoid tissues. In normal lymphoid tissue, CD20 [L26] marks B-cells in germinal centers, particularly immunoblasts. This antibody has been shown to be a reliable pan B-cell marker. Studies also show CD20 [L26] marking diffuse large B-cell lymphomas. CD20 [L26] rarely marks T-cells.
|Download Data Sheet
|Download RUO Data Sheet for International
|Download SDS Sheet
Regulatory Notice: Biocare’s IVD-labeled products comply with US-FDA and European IVDD regulation. Other regions may have additional requirements for such labeling, please contact your local distributor.
1. Kitamura A, et al. Histopathology. 2005 Nov; 47(5):523-32.
2. Tao K, et al. Zhonghua Bing Li Xue Za Zhi. 2002 Apr; 31(2):112-5.
3. Chen CC, et al. Appl Immunohistochem Mol Morphol. 2000 Mar; 8(1):1-11.